AI-driven memory and storage shortages may push DRAM up 50%+ in 2026, aiding Micron, Sandisk, Nvidia and more while ...

Nvidia has accelerated its expansion into artificial intelligence inference by signing a non-exclusive licensing agreement with startup Groq. The deal gives Nvidia access to specialized chip ...

Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...

This is read by an automated voice. Please report any issues or inconsistencies here. President Trump said Monday that he would allow Nvidia to sell an advanced type of computer chip used in the ...

There have been concerns about allowing advanced computer chips to be sold to China, as it could help the country better compete against the U.S. in building out AI capabilities. But there has also ...

WASHINGTON (AP) — President Donald Trump said Monday that he would allow Nvidia to sell an advanced type of computer chip used in the development of artificial intelligence to “approved customers” in ...

President Donald Trump touched on two major trade matters back-to-back on Monday, approving the sale of Nvidia chips to China and threatening Mexico with a 5% tariff over water rights. Trump’s first ...

President Trump on Monday announced that he will greenlight the sale of Nvidia's (NVDA) more powerful H200 chips to China. Trump previously lifted restrictions on the sale of Nvidia's China-specific ...

President Donald Trump said on Monday that he has informed President Xi Jinping of China that "the United States will allow NVIDIA to ship its H200 products to approved customers in China." Nvidia's ...

Approval for the H200 chip followed months of haggling between tech industry backers and defense hawks. By Tripp Mickle and Ana Swanson Tripp Mickle reported from San Francisco, and Ana Swanson from ...

In the pharma industry, when a generic drug wins approval, it creates a structural market shift. Being therapeutically equivalent to the branded drug, but 80–85% cheaper, generics quickly capture ...